Press Release

PhRMA Statement on the Health Care Reform Agreement

PhRMA April 30, 2013

Washington, D.C. (June 21, 2009) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement regarding the agreement with the White House and the Senate Finance Committee to help close the coverage gap in the Medicare prescription drug program:

“This marks an important first step toward our shared goal of providing high-quality, affordable health care to everyone in America.  We applaud President Obama and Senate Finance Committee Chairman Baucus for their commitment to comprehensive health care reform – one of the most challenging issues of our lifetime.  Health care reform is important to patients, the economy and the future of America.   

“Millions of uninsured and financially-struggling Americans are depending on us to accomplish comprehensive health care reform this year.  America’s pharmaceutical research and biotechnology companies are signaling their strong support for these critically important efforts.  This is a once-in-a-lifetime opportunity and, working together, we can make this hope for a better tomorrow a reality today.”

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: 

For information on how innovative medicines save lives, visit:

For information on the Partnership for Prescription Assistance, visit:

For more information on public health emergencies, visit:

For information on the danger of imported drugs, visit: